Your browser doesn't support javascript.
loading
The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.
Kusafuka, Kimihide; Sato, Yoko; Nakatani, Eiji; Baba, Satoshi; Maeda, Matsuyoshi; Yamanegi, Koji; Ueda, Kaori; Inagaki, Hiroshi; Otsuki, Yoshiro; Kuroda, Naoto; Suzuki, Kensuke; Iwai, Hiroshi; Imamura, Yoshiaki; Itakura, Junya; Yamanaka, Shoji; Takahashi, Hideaki; Ito, Ichiro; Akashi, Takumi; Daa, Tsutomu; Hamada, Mei; Yasuda, Masanori; Kawata, Ryo; Yamamoto, Hidetaka; Tachibana, Yuri; Fukuoka, Junya; Muramatsu, Aya; Arai, Kazumori; Suzuki, Makoto.
Afiliação
  • Kusafuka K; Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
  • Sato Y; Division of Clinical Biostatistics, Research Support Center, Shizuoka General Hospital, Shizuoka, Japan.
  • Nakatani E; Division of Clinical Biostatistics, Research Support Center, Shizuoka General Hospital, Shizuoka, Japan.
  • Baba S; Department of Diagnostic Pathology, Hamamatsu University School of Medicine Hospital, Shizuoka, Japan.
  • Maeda M; Department of Clinical Pathology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Yamanegi K; Department of Pathology, Hyogo Medical College, Hyogo, Japan.
  • Ueda K; Department of Pathology and Molecular Diagnostics, Nagoya City University, Nagoya, Japan.
  • Inagaki H; Department of Pathology and Molecular Diagnostics, Nagoya City University, Nagoya, Japan.
  • Otsuki Y; Department of Pathology, Seirei Hamamatsu General Hospital, Shizuoka, Japan.
  • Kuroda N; Department of Diagnostic Pathology, Kobe Koudou Hospital Center, Kobe, Japan.
  • Suzuki K; Department of Otolaryngology - Head and Neck Surgery, Kansai Medical University, Osaka, Japan.
  • Iwai H; Department of Otolaryngology - Head and Neck Surgery, Kansai Medical University, Osaka, Japan.
  • Imamura Y; Division of Diagnostic Pathology/Surgical Pathology, University of Fukui Hospital, Fukui, Japan.
  • Itakura J; Department of Anatomic Pathology, Kurashiki Central Hospital, Okayama, Japan.
  • Yamanaka S; Department of Diagnostic Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Takahashi H; Department of Otorhinolaryngology - Head and Neck Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Ito I; Department of Diagnostic Pathology, Nagano Red Cross Hospital, Nagano, Japan.
  • Akashi T; Division of Surgical Pathology, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
  • Daa T; Department of Diagnostic Pathology, Oita University, Oita, Japan.
  • Hamada M; Department of Diagnostic Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Yasuda M; Department of Diagnostic Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Kawata R; Department of Otorhinolaryngology - Head and Neck Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Yamamoto H; Department of Anatomic Pathology, Kyushu University, Fukuoka, Japan.
  • Tachibana Y; Department of Pathology, Nagasaki University, Nagasaki, Japan.
  • Fukuoka J; Department of Pathology, Nagasaki University, Nagasaki, Japan.
  • Muramatsu A; Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
  • Arai K; Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
  • Suzuki M; Department of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
Head Neck ; 44(6): 1430-1441, 2022 06.
Article em En | MEDLINE | ID: mdl-35352425
ABSTRACT

BACKGROUND:

Salivary duct carcinoma (SDC) is a high-grade salivary malignancy that frequently occurs as the carcinomatous component of carcinoma ex pleomorphic adenoma. We herein examined the clinical factors affecting outcomes in a large cohort of SDC.

METHODS:

We selected 304 SDC cases and investigated clinical characteristics and the factors affecting outcomes.

RESULTS:

The median age of the cases examined was 68 years, the most common primary site was the parotid gland (238 cases), and there was a male predominance (M/F = 51). Outcomes were significantly worse when the primary tumor site was the minor salivary glands (SG) than when it was the major SG. Outcomes were also significantly worse in pN(+) cases (161 cases) than in pN0 cases, particularly those with a metastatic lymph node number ≥11. The cumulative incidence of relapse and distant metastases was significantly higher in stage IV cases than in stage 0-III cases.

CONCLUSIONS:

The absolute number of lymph node metastases, higher stages, and the minor SG as the primary tumor site were identified as factors affecting the outcome of SDC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Salivares / Adenoma Pleomorfo / Carcinoma Ductal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Salivares / Adenoma Pleomorfo / Carcinoma Ductal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
...